Junyoung Choi
Pohang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Correction: Highly-efficient and scalable TrioN (3N0C) synaptic cell for analog process-in-memory.
Journal: Materials horizons
Published: January 23, 2026
Highly-efficient and scalable TrioN (3N0C) synaptic cell for analog process-in-memory.
Journal: Materials horizons
Published: June 25, 2025
Analog Switching in Hexagonal Boron Nitride Memristors via Multiple Nano-Filaments Confinement.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: April 11, 2025
Biomolecular condensate assembly of nArgBP2 tunes its functionality to manifest the structural plasticity of dendritic spines.
Journal: Experimental & molecular medicine
Published: July 20, 2022
Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer.
Journal: American journal of cancer research
Published: June 29, 2020
Transglutaminase 2 induces intrinsic EGFR-TKI resistance in NSCLC harboring EGFR sensitive mutations.
Journal: American journal of cancer research
Published: July 04, 2019
The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205.
Journal: American journal of cancer research
Published: January 23, 2019
HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2.
Journal: Cancer letters
Published: July 19, 2017
The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib.
Journal: Cancer letters
Published: October 14, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026